1. Academic Validation
  2. Ninjurin1 regulates lipopolysaccharide-induced inflammation through direct binding

Ninjurin1 regulates lipopolysaccharide-induced inflammation through direct binding

  • Int J Oncol. 2016 Feb;48(2):821-8. doi: 10.3892/ijo.2015.3296.
Min Wook Shin 1 Sung-Jin Bae 1 Hee-Jun Wee 1 Hyo-Jong Lee 2 Bum Ju Ahn 1 Hoang Le 1 Eun Ji Lee 1 Ran Hee Kim 1 Hye Shin Lee 1 Ji Hae Seo 1 Ji-Hyeon Park 1 Kyu-Won Kim 1
Affiliations

Affiliations

  • 1 SNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea.
  • 2 College of Pharmacy, Inje University, Gimhae, Gyugnam 621-749, Republic of Korea.
Abstract

Ninjurin1 is a transmembrane protein involved in macrophage migration and adhesion during inflammation. It was recently reported that repression of Ninjurin1 attenuated the lipopolysaccharide (LPS)-induced inflammatory response in macrophages; however, the precise mechanism by which Ninjurin1 modulates LPS-induced inflammation remains poorly understood. In the present study, we found that the interaction between Ninjurin1 and LPS contributed to the LPS-induced inflammatory response. Notably, pull-down assays using lysates from HEK293T cells transfected with human or mouse Ninjurin1 and biotinylated LPS (LPS-biotin) showed that LPS directly bound Ninjurin1. Subsequently, LPS binding assays with various truncated forms of Ninjurin1 protein revealed that Amino acids (aa) 81-100 of Ninjurin1 were required for LPS binding. In addition, knockdown experiments using Ninj1 siRNA resulted in decreased nitric oxide (NO) and tumor necrosis factor-α (TNFα) secretion upon LPS treatment in Raw264.7 cells. Collectively, our results suggest that Ninjurin1 regulates the LPS-induced inflammatory response through its direct binding to LPS, thus, identifying Ninjurin1 as a putative target for the treatment of inflammatory diseases, such as sepsis and inflammation-associated carcinogenesis.

Figures